The largest database of trusted experimental protocols

Eclipse ti u inverted research microscope

Manufactured by Nikon
Sourced in Japan

The Eclipse Ti-U is an inverted research microscope designed for a wide range of applications. It features a stable and ergonomic design, supporting high-resolution imaging and advanced techniques. The microscope provides a versatile platform for researchers to conduct their investigations.

Automatically generated - may contain errors

2 protocols using eclipse ti u inverted research microscope

1

Brightfield and Confocal Microscopy of Dunaliella

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Eclipse Ti-U inverted research microscope (Nikon, Tokyo, Japan) with a Nikon Digital Sight DS-Fi1 camera system was used to take brightfield microscopy photographs of cells of each Dunaliella strain. The objective lens used was Nikon Splan Fluor ELWD 60×/0.7 and the ocular lens was Nikon CFI 10×/22. The NIS-Elements Advanced Research Microscope Imaging Software (Nikon, Tokyo, Japan) was used to acquire the photos. Differential interference contrast (DIC) microscopy photographs were also obtained using a confocal microscope system ZEISS LSM 880 (Carl Zeiss Microscopy GmbH, Jena, Germany). The ZEISS Plan Apochromat 63×/1.4 oil DIC objective lens and the Carl Zeiss PI 10×/23 ocular lens were used. Images were acquired and analyzed through the ZEN 2.1 LSM software (Carl Zeiss Microscopy GmbH).
+ Open protocol
+ Expand
2

Endothelial-to-Mesenchymal Transition Induction

Check if the same lab product or an alternative is used in the 5 most similar protocols
EndoMT was induced by changing medium to an EndoMT-inducing medium that contained Stempro34 medium with Stempro34 supplement (Life Science Technology Corp.), L-glutamine (Life Technologies Corp.), penicillin–streptomycin (Life Technologies Corp.), 200 ng ml−1 BMP2 (Peprotech Inc.) and 50 ng ml−1 TGFβ2 (Peprotech Inc.). Non-EndoMT control groups were kept in EC medium containing Stempro34 (Life Technologies Corp.), Stempro34 supplement (Life Technologies Corp.), L-glutamine (Life Technologies Corp.), penicillin–streptomycin (Life Technologies Corp.) and 50 ng ml−1 vascular endothelial growth factor (Peprotech Inc.). Cells were collected 3 days after induction.
Type I collagen (Sigma Corp.) at 1 mg ml−1 (final concentration) was mixed with Stempro34 medium, Stempro34 supplement (Life Science Technology Corp.) and 50 mM NaOH (Sigma Corp.). The mixture was poured into 24-well tissue culture plates (0.5 ml per well) and allowed to gel in 5% CO2 incubator at 37 °C for 30 min. And then 0.5 ml EndoMT-inducing medium was added. After 3 days, pictures of cells were taken with 100 times magnificance under the Eclipse Ti-U inverted research microscope (Nikon Corp.). Mesenchymal cells that migrated out in three pictures from different fields were counted. Experiments were repeated three times. Average value and standard derivation were plotted.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!